EARNINGS: Shortwave Life Sciences half-year loss widens
30th Jan 2026 22:01
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
| Price | 295.00p on 26-03-2026 at 19:30:06 |
|---|---|
| Change | -2.00p -0.67% |
| Buy | 298.00p |
| Sell | 292.00p |
| Last Trade: | Sell 3,495.00 at 292.00p |
| Day's Volume: | 57,294 |
| Last Close: | 295.00p |
| Open: | 297.00p |
| ISIN: | GB00B2PP2527 |
| Day's Range | 295.00p - 297.00p |
| 52wk Range: | 242.00p - 316.00p |
| Market Capitalisation: | £277.55m |
| VWAP: | 294.31823p |
| Shares in Issue: | 94.09m |
Sector: Closed End Investments
Ct Global Grwth (CMPG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,495 | 292.00p | Ordinary |
16:21:34 - 26-Mar-26 |
| Sell* | 3,495 | 294.00p | Ordinary |
16:17:54 - 26-Mar-26 |
| Unknown* | 37,654 | 293.662p | Ordinary |
12:46:29 - 26-Mar-26 |
| Unknown* | 12,650 | 297.00p | Ordinary |
12:46:06 - 26-Mar-26 |
| Sell* | 5,114 | 294.00p | Ordinary |
15:01:01 - 25-Mar-26 |
| Sell* | 179 | 294.00p | Ordinary |
14:17:59 - 25-Mar-26 |
| Unknown* | 4,845 | 297.00p | Ordinary |
12:14:12 - 25-Mar-26 |
| Sell* | 1,407 | 296.16p | Ordinary |
08:24:59 - 25-Mar-26 |
| Sell* | 1 | 296.16p | Ordinary |
14:13:22 - 24-Mar-26 |
| Unknown* | 23,202 | 296.379p | Ordinary |
11:52:20 - 24-Mar-26 |
Ct Global Grwth (CMPG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 25th Mar 2026 12:37 pm | RNS | Net Asset Value(s) |
| 24th Mar 2026 12:41 pm | RNS | Net Asset Value(s) |
| 23rd Mar 2026 12:37 pm | RNS | Net Asset Value(s) |
| 20th Mar 2026 12:54 pm | RNS | Net Asset Value(s) |
| 19th Mar 2026 1:40 pm | RNS | Net Asset Value(s) |
| 18th Mar 2026 12:35 pm | RNS | Net Asset Value(s) |
| 17th Mar 2026 12:39 pm | RNS | Net Asset Value(s) |
| 16th Mar 2026 12:31 pm | RNS | Net Asset Value(s) |
| 12th Mar 2026 5:21 pm | RNS | Portfolio Update |
| 10th Mar 2026 12:58 pm | RNS | Net Asset Value(s) |